• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与5-氟尿嘧啶和卡铂相关的短暂性昏迷和脑病体征:一例报告

Transient Coma and Signs of Encephalopathy Related to 5-Fluorouracil and Carboplatin: A Case Report.

作者信息

Zupancic Mark, Farrajota Neves da Silva Pedro, Kas Elyas Karam, Friesland Signe, Ellingsen Cederö Thomasine, Gerling Marco

机构信息

Medical Unit Head, Neck, Lung, and Skin Cancer, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.

Department of Oncology-Pathology, Karolinska Institutet, Solna, Sweden.

出版信息

Case Rep Oncol. 2023 Jul 13;16(1):525-531. doi: 10.1159/000531472. eCollection 2023 Jan-Dec.

DOI:10.1159/000531472
PMID:37485017
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10359680/
Abstract

Chemotherapy-related encephalopathy is a rare but severe side effect of cancer therapy. Few reports exist on the course of encephalopathy due to 5-fluorouracil (5FU)/carboplatin treatment. Here, we report on a patient in his 70s, who received first-line palliative treatment with carboplatin followed by continuous infusion of 5FU against a metastasized cancer of the base of the tongue. During the first 5FU infusion, the patient developed a coma with sudden onset. In contrast to earlier reports of 5FU-induced encephalopathy, serum ammonium levels were near-normal, despite a slightly increased bilirubin. The electroencephalogram showed signs of general encephalopathy, for which no other probable cause than chemotherapy could be identified. Based on historical reports, the patient's encephalopathy was likely due to 5FU treatment rather than carboplatin. While initially in a coma with a Glasgow Coma Scale score of three, the patient regained consciousness within 3 days of supportive therapy. This case highlights the potentially benign clinical course of 5FU-induced encephalopathy, characterized by fulminant clinical deterioration and quick recovery. Such a rapid deterioration in a palliative setting can pose a clinical dilemma, where invasive treatments such as intubation must be weighed against a limited prognosis, for which this case may provide guidance.

摘要

化疗相关性脑病是癌症治疗中一种罕见但严重的副作用。关于5-氟尿嘧啶(5FU)/卡铂治疗所致脑病的病程,相关报道较少。在此,我们报告一例70多岁的患者,其接受了卡铂一线姑息治疗,随后持续输注5FU以治疗舌根部转移性癌。在首次输注5FU期间,患者突然昏迷。与早期关于5FU诱导性脑病的报道不同,尽管胆红素略有升高,但血清铵水平接近正常。脑电图显示有全身性脑病的迹象,除化疗外未发现其他可能病因。根据既往报道,该患者的脑病可能是由5FU治疗而非卡铂引起的。患者最初昏迷,格拉斯哥昏迷量表评分为3分,但在支持治疗3天内恢复了意识。该病例突出了5FU诱导性脑病潜在的良性临床病程,其特点是临床迅速恶化但恢复较快。在姑息治疗中如此迅速的恶化可能会带来临床困境,即必须权衡诸如插管等侵入性治疗与有限的预后,该病例或许能提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/10359680/b3da3d318bbf/cro-2023-0016-0001-531472_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/10359680/b3da3d318bbf/cro-2023-0016-0001-531472_F01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/10359680/b3da3d318bbf/cro-2023-0016-0001-531472_F01.jpg

相似文献

1
Transient Coma and Signs of Encephalopathy Related to 5-Fluorouracil and Carboplatin: A Case Report.与5-氟尿嘧啶和卡铂相关的短暂性昏迷和脑病体征:一例报告
Case Rep Oncol. 2023 Jul 13;16(1):525-531. doi: 10.1159/000531472. eCollection 2023 Jan-Dec.
2
Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.卡铂/5-氟尿嘧啶作为顺铂/5-氟尿嘧啶的替代方案用于转移性和复发性头颈部鳞状细胞癌及鼻咽癌。
Asian Pac J Cancer Prev. 2013;14(2):1121-6. doi: 10.7314/apjcp.2013.14.2.1121.
3
Stability studies on admixtures of 5-fluorouracil with carboplatin and 5-fluorouracil with heparin for administration in continuous infusion regimens.5-氟尿嘧啶与卡铂及5-氟尿嘧啶与肝素混合液用于持续输注方案给药的稳定性研究。
J Clin Pharm Ther. 1994 Apr;19(2):127-33. doi: 10.1111/j.1365-2710.1994.tb01124.x.
4
[Coma following chemotherapy: is 5FU implicated? Discussion about on case-report].化疗后昏迷:5-氟尿嘧啶有牵连吗?关于一例病例报告的讨论
Gastroenterol Clin Biol. 2006 Feb;30(2):325-6. doi: 10.1016/s0399-8320(06)73176-1.
5
Delayed-onset encephalopathy and coma in acute organophosphate poisoning in humans.人类急性有机磷中毒中的迟发性脑病与昏迷
Neurotoxicology. 2008 Mar;29(2):335-42. doi: 10.1016/j.neuro.2008.01.004. Epub 2008 Jan 21.
6
[Fatal acute encephalopathy due to 5-fluorouracil treatment].[5-氟尿嘧啶治疗所致的致命性急性脑病]
Presse Med. 2005 Dec 3;34(21):1637-40. doi: 10.1016/s0755-4982(05)84240-x.
7
Hyperammonemic Encephalopathy Associated with 5-Flurouracil Infusion in Head and Neck Cancer: Case Report and Review of the Literature.头颈部癌患者5-氟尿嘧啶输注相关的高氨血症性脑病:病例报告及文献复习
J Neurosci Rural Pract. 2021 Sep 28;12(4):811-812. doi: 10.1055/s-0041-1736154. eCollection 2021 Oct.
8
Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus.比较新辅助放化疗联合卡铂/紫杉醇或顺铂/ 5-氟尿嘧啶治疗食管鳞癌的疗效。
Radiat Oncol. 2017 Nov 21;12(1):182. doi: 10.1186/s13014-017-0904-y.
9
Shifting practice in definitive chemoradiation for localized esophageal cancer.局部食管癌确定性放化疗的实践转变
Curr Oncol. 2017 Oct;24(5):e379-e387. doi: 10.3747/co.24.3677. Epub 2017 Oct 25.
10
The value of oxaliplatin in combination with continuous infusion +/- bolus 5-fluorouracil and levo-folinic acid in metastatic colorectal cancer progressing after 5FU-based chemotherapy: a GISCAD (Italian Group for the Study of Digestive Tract) cancer phase II trial.奥沙利铂联合持续输注±推注5-氟尿嘧啶和亚叶酸钙用于经基于5-氟尿嘧啶的化疗后进展的转移性结直肠癌的价值:一项GISCAD(意大利消化道研究组)癌症II期试验。
Tumori. 2000 Nov-Dec;86(6):465-9. doi: 10.1177/030089160008600606.

引用本文的文献

1
Economic Model of Uridine Triacetate Versus Supportive Care for the Treatment of Patients with Life-Threatening Early-Onset Severe Toxicity.尿苷三乙酸酯与支持性治疗用于治疗危及生命的早发性严重毒性患者的经济模型
Clin Drug Investig. 2025 Mar;45(3):111-123. doi: 10.1007/s40261-025-01426-x. Epub 2025 Feb 22.

本文引用的文献

1
Case report: Uridine triacetate in the management of delayed onset 5-fluorouracil toxicity: A case report and review of literature.病例报告:三乙酸尿苷治疗5-氟尿嘧啶延迟性毒性:一例病例报告及文献综述
Front Pharmacol. 2022 Sep 7;13:977734. doi: 10.3389/fphar.2022.977734. eCollection 2022.
2
A unique presentation of 5-fluorouracil (5-FU) induced cerebral encephalopathy.5-氟尿嘧啶(5-FU)诱发的脑性脑病的一种独特表现。
Indian J Radiol Imaging. 2020 Apr-Jun;30(2):214-217. doi: 10.4103/ijri.IJRI_17_19. Epub 2020 Jul 13.
3
Individualized Dosing of Fluoropyrimidine-Based Chemotherapy to Prevent Severe Fluoropyrimidine-Related Toxicity: What Are the Options?
氟嘧啶类化疗药物个体化剂量以预防严重氟嘧啶相关毒性:有哪些选择?
Clin Pharmacol Ther. 2021 Mar;109(3):591-604. doi: 10.1002/cpt.2069. Epub 2020 Nov 12.
4
5-Fluorouracil-induced encephalopathy.5-氟尿嘧啶诱发的脑病。
Cleve Clin J Med. 2020 Aug 31;87(9):532-533. doi: 10.3949/ccjm.87a.19126.
5
Fluoropyrimidine-induced toxicity and DPD deficiency.. A case report of early onset, lethal capecitabine-induced toxicity and mini review of the literature. Uridine triacetate: Efficacy and safety as an antidote. Is it accessible outside USA?氟嘧啶诱导的毒性与二氢嘧啶脱氢酶缺乏症:一例早期发生的致命性卡培他滨诱导毒性病例报告及文献综述。三醋酸尿苷:作为解毒剂的疗效与安全性。在美国以外地区是否可获取?
J Oncol Pharm Pract. 2020 Apr;26(3):747-753. doi: 10.1177/1078155219865597. Epub 2019 Aug 5.
6
5-Fluorouracil rechallenge after 5-fluorouracil-induced hyperammonemic encephalopathy.5-氟尿嘧啶诱导的高氨血症性脑病后再次使用5-氟尿嘧啶
Anticancer Drugs. 2019 Mar;30(3):313-317. doi: 10.1097/CAD.0000000000000730.
7
5-fluorouracil and cardiotoxicity: a review.5-氟尿嘧啶与心脏毒性:综述
Ther Adv Med Oncol. 2018 Jun 18;10:1758835918780140. doi: 10.1177/1758835918780140. eCollection 2018.
8
Acute reversible toxic encephalopathy during capecitabine and oxaliplatin treatment.卡培他滨和奥沙利铂治疗期间的急性可逆性中毒性脑病。
J Oncol Pharm Pract. 2019 Mar;25(2):497-501. doi: 10.1177/1078155217739686. Epub 2017 Nov 9.
9
Chemotherapy induced stroke mimic: 5-Fluorouracil encephalopathy fulfilling criteria for tissue plasminogen activator therapy.化疗诱发的类卒中:符合组织型纤溶酶原激活剂治疗标准的5-氟尿嘧啶脑病
Am J Emerg Med. 2017 Sep;35(9):1389-1390. doi: 10.1016/j.ajem.2017.07.022. Epub 2017 Jul 6.
10
Chemotherapy-associated Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.化疗相关的后部可逆性脑病综合征:一例报告及文献复习
Neurologist. 2016 Nov;21(6):112-117. doi: 10.1097/NRL.0000000000000105.